Skip to main content
Jeffrey Guptill, MD, Neurology, Durham, NC, Duke University Hospital

JeffreyTalbotGuptillMD

Neurology Durham, NC

Neuroimmunology/Multiple Sclerosis, Neuromuscular Medicine

Assistant Professor of Medicine, Duke University School of Medicine

Dr. Guptill is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Guptill's full profile

Already have an account?

Education & Training

  • UCB Pharma
    UCB PharmaNeurology Clinical Development, 2011 - 2012
  • Duke University School of Medicine
    Duke University School of MedicineMHS, Clinical Research Training Program, 2010 - 2012
  • Duke University Hospital
    Duke University HospitalFellowship, Duke Clinical Research Institute, 2010 - 2011
  • Duke University Hospital
    Duke University HospitalFellowship, Neuromuscular Medicine (Neurology), 2010 - 2011
  • Duke University Hospital
    Duke University HospitalFellowship, Neuromuscular Medicine (Neurology), 2009 - 2010
  • Duke University Hospital
    Duke University HospitalResidency, Neurology, 2006 - 2009
  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemInternship, Internal Medicine, 2005 - 2006
  • Virginia Commonwealth University School of Medicine
    Virginia Commonwealth University School of MedicineClass of 2005

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2009 - 2023
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Duke Neurology Research Round up, June 2021
    Duke Neurology Research Round up, June 2021June 1st, 2021
  • A Chimeric Hemagglutinin-Based Universal Influenza Virus Vaccine Approach Induces Broad and Long-Lasting Immunity in a Randomized, Placebo-Controlled Phase I Trial
    A Chimeric Hemagglutinin-Based Universal Influenza Virus Vaccine Approach Induces Broad and Long-Lasting Immunity in a Randomized, Placebo-Controlled Phase I TrialDecember 7th, 2020
  • Sanford Burnham Prebys Gets $3.58 Million to Advance Treatment for Opioid Misuse
    Sanford Burnham Prebys Gets $3.58 Million to Advance Treatment for Opioid MisuseOctober 23rd, 2019
  • Join now to see all

Hospital Affiliations